1Celermajer DS, Sorensen KE, Gooch V M, et al. Non-inva-sive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet , 1992, 340 : 1111-1115.
2Allen JD, Wilson JB, Tulley RT, et al. Influence of age and normal plasma fibrinogen levels on flow-mediated dilation in healthy adults. Am J Cardiol, 2000, 86:703-705 A9.
3Sarabi M, Millgard J, Lind L. Effects of age, gender and metabolic factors on endothelium-dependent vasodilation: a population-based study. J Intern Med, 1999, 246: 265-274.
4Gerhard M, Roddy MA, Creager S J, et al. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension , 1999, 7: 49-53.
5Koh KK, Jin DK, Yang SH, et al. Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation,2001, 103: 1961-1966.
6Yataco AR, Corretti MC, Gardner AW, et al. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol , 1999, 83- 754-758.
7Koh KK, Cardillo C, Bui MN, et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation, 1999, 99: 354-360.
8Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al.Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res, 1999, 43: 985-991.
9Butler R, Morris AD, Burchell B, et al. DD angiotensin-con-verting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. Hypertension, 1999, 33:1164-1168.
10Schachinger V, Britten MB, Dimmeler S, et al. NADH/NAD-PH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur Heart J,2001, 22: 96-101.
同被引文献11
1Loiko EN,Samal AB,Shulyakovskaya SM.H2O2-induced platelet aggregation and increase in intracellular Ca2+ concentration are blocked by inhibitors of intracellular signaling.Biochenmistry,2003,68,1210-1216.
2Burnett AL.The role of nitric oxide in erectile dysfunction,implications for medical therapy.J Clin Hypertens,2006,8,53-62.
3Pereira J,Soto M,Palomo I,et al.Platelet aging in vivo is associated with activation of apoptotic pathways,studies in a model of suppressed thrombopoiesis in dogs.Thromb Haemost,2002,87,905-909.
4Bastyr EJ 3rd,Kadrofske MM,Vinik AI.Platelet activity and phosphoinositide turnover increase with advancing age.Am Med,1990,88,601-606.
5Kone BC.Molecular biology of natriuretic peptides and nitric oxide synthases.Cardiovasc Res,2001,51,429-441.
6Frere C,Cuisset T,Ouilici J,et al.ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome.Thromb Haemost,2007,98,838-943.
8Kang LS,Reyes RA,Muller-Delp JM.Aging impairs flow-induced dilation in coronary arterioles,role of NO and H2O2.Am J Physiol Hear Circ Physiol,2009,297,H1087-1095.
9Lim MJ,Eagle KA,Gore JM,et al.Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events).Am J Cardiol,2005,96,917-921.
10Gresele P,Momi S.Pharmacologic profile and therapeutic potential of NCX 4016,a nitric oxide-releasing aspirin,for cardiovascular disorders.Cardiovasc Drug Rev,2006,24,148-168.
